Tag: gene clusters

Categories
Uncategorized

🌟 Revolutionizing Natural Product Discovery with Advanced Cloning Techniques! 🌟

🧑‍🔬 Our colleagues Olena Kurylenko and Yuriy Rebets have published an article on advancement in the field of microbial biotechnology by developing an improved transformation-associated recombination (TAR) cloning approach for capturing natural product biosynthetic gene clusters (BGCs). This innovative method, utilizing the yeast killer phenomenon, significantly enhances the efficiency and precision of cloning large gene clusters from Actinobacteria, particularly the genus Streptomyces.

🔬 Why This Matters:

  1. 🧬 Enhanced Cloning Efficiency:
    🔹 The new TAR cloning vector system allows for direct selection of colonies carrying the desired BGCs, reducing the need for intensive screening.
    🔹 Successfully cloned large BGCs, such as the chelocardin (35 kb) from Amycolatopsis sulphurea and daptomycin (67 kb) from Streptomyces filamentosus, were functionally expressed in a heterologous host.
  2. 🧫 Broader Applications:
    🔹 This approach can be widely applied to precisely clone BGCs from various representatives of the Actinomycetota phylum and can be easily adapted for other bacteria.
    🔹 The method supports the discovery of diverse bioactive natural products, which are crucial for developing new antibiotics and other pharmaceuticals.
  3. ⚙️ Sustainability and Innovation:
    🔹 By streamlining the cloning process, this technique promotes sustainable practices in natural product research and biotechnology.
    🔹 It opens up new possibilities for exploring the vast chemical diversity of natural products and their potential applications in medicine and industry.

🌱 The Future of Natural Product Discovery:

This research represents a significant step forward in the quest to discover the true power of natural products for pharmaceutical and industrial applications. By improving the efficiency and precision of cloning large gene clusters, we are opening the way for the discovery of novel bioactive compounds that could lead to the development of new drugs and therapies.

🔗Read full article here: https://enviromicro-journals.onlinelibrary.wiley.com/doi/10.1111/1751-7915.70067

Categories
Uncategorized

🌟 Unlocking Nature’s Hidden Arsenal: The Genetic Secrets of Limocrocin 🌟

In the recent study, our colleagues Sofia Melnyk and Yuriy Rebets with our partners from Ivan Franko National University of Lviv, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), and German-Ukrainian Core of Excellence in Natural Products Research (CENtR) have successfully uncovered the genetic basis behind the production of limocrocin (LIM), a remarkable antiviral polyketide. This incredible feat was achieved through the in-depth study of biosynthetic gene clusters (smBGCs) in the bacterium Streptomyces roseochromogenes.

🧬What are biosynthetic gene clusters?

Biosynthetic gene clusters are groups of co-located genes that work together to produce complex molecules. In this case, we delved into the smBGCs of Streptomyces roseochromogenes to identify the genes responsible for producing limocrocin.

Actinomycete genomes harbor dozens of BGCs for the production of diverse specialized metabolites. Majority of these BGCs, however, remain cryptic under typical laboratory conditions. Our work sheds the light on the biosynthesis of LIM family compounds in bacteria, which had remained unknown for seven decades, and offers a convenient biological platform to overproduce LIM and generate its analogs.

🔍 Why does this matter?

Limocrocin has shown significant potential in interfering with viral reverse transcriptases, which are enzymes that certain viruses use to replicate their genetic material. This makes limocrocin a promising candidate for antiviral therapies. By unraveling the genetic code behind its production, we can now explore ways to enhance its production and develop new derivatives with even better antiviral properties.

💡 The implications are profound:

💊 Enhanced Antiviral Therapies: With a deeper understanding of limocrocin biosynthesis, researchers can engineer bacteria to produce larger quantities of this compound, paving the way for more effective antiviral drugs.
🧑‍🔬 New Drug Derivaties: The genetic knowledge allows scientists to tweak the biosynthetic pathways, creating new limocrocin derivatives that could be even more effective against viruses.
🌱 Biotechnological Advances: This research exemplifies how exploring natural biosynthetic pathways can lead to novel biotechnological innovations, potentially uncovering other valuable compounds in the future.

🔗Read full article here: https://bit.ly/3EnYEMu